123 related articles for article (PubMed ID: 33894703)
21. Somatic KCNJ5 mutation occurring early in adrenal development may cause a novel form of juvenile primary aldosteronism.
Tamura A; Nishimoto K; Seki T; Matsuzawa Y; Saito J; Omura M; Gomez-Sanchez CE; Makita K; Matsui S; Moriya N; Inoue A; Nagata M; Sasano H; Nakamura Y; Yamazaki Y; Kabe Y; Mukai K; Kosaka T; Oya M; Suematsu S; Nishikawa T
Mol Cell Endocrinol; 2017 Feb; 441():134-139. PubMed ID: 27514282
[TBL] [Abstract][Full Text] [Related]
22. NP-59 Adrenal Scintigraphy as an Imaging Biomarker to Predict
Lu CC; Yen RF; Peng KY; Huang JY; Wu KD; Chueh JS; Lin WY
Front Endocrinol (Lausanne); 2021; 12():644927. PubMed ID: 33995277
[TBL] [Abstract][Full Text] [Related]
23. Double adrenocortical adenomas harboring independent KCNJ5 and PRKACA somatic mutations.
Nanba K; Omata K; Tomlins SA; Giordano TJ; Hammer GD; Rainey WE; Else T
Eur J Endocrinol; 2016 Aug; 175(2):K1-6. PubMed ID: 27165862
[TBL] [Abstract][Full Text] [Related]
24. Immunohistochemical, genetic and clinical characterization of sporadic aldosterone-producing adenomas.
Monticone S; Castellano I; Versace K; Lucatello B; Veglio F; Gomez-Sanchez CE; Williams TA; Mulatero P
Mol Cell Endocrinol; 2015 Aug; 411():146-54. PubMed ID: 25958045
[TBL] [Abstract][Full Text] [Related]
25. Genetics of Aldosterone-Producing Adenoma in Korean Patients.
Hong AR; Kim JH; Song YS; Lee KE; Seo SH; Seong MW; Shin CS; Kim SW; Kim SY
PLoS One; 2016; 11(1):e0147590. PubMed ID: 26807823
[TBL] [Abstract][Full Text] [Related]
26. Somatic ATP1A1, ATP2B3, and KCNJ5 mutations in aldosterone-producing adenomas.
Williams TA; Monticone S; Schack VR; Stindl J; Burrello J; Buffolo F; Annaratone L; Castellano I; Beuschlein F; Reincke M; Lucatello B; Ronconi V; Fallo F; Bernini G; Maccario M; Giacchetti G; Veglio F; Warth R; Vilsen B; Mulatero P
Hypertension; 2014 Jan; 63(1):188-95. PubMed ID: 24082052
[TBL] [Abstract][Full Text] [Related]
27. Novel genes in primary aldosteronism.
Fischer E; Beuschlein F
Curr Opin Endocrinol Diabetes Obes; 2014 Jun; 21(3):154-8. PubMed ID: 24739312
[TBL] [Abstract][Full Text] [Related]
28. 18-Oxocortisol Synthesis in Aldosterone-Producing Adrenocortical Adenoma and Significance of KCNJ5 Mutation Status.
Tezuka Y; Yamazaki Y; Kitada M; Morimoto R; Kudo M; Seiji K; Takase K; Kawasaki Y; Mitsuzuka K; Ito A; Nishikawa J; Asai N; Nakamura Y; Gomez-Sanchez CE; Ito S; Dezawa M; Sasano H; Satoh F
Hypertension; 2019 Jun; 73(6):1283-1290. PubMed ID: 31006333
[TBL] [Abstract][Full Text] [Related]
29.
Chang YY; Tsai CH; Peng SY; Chen ZW; Chang CC; Lee BC; Liao CW; Pan CT; Chen YL; Lin LC; Chang YR; Peng KY; Chou CH; Wu VC; Hung CS; Lin YH;
Hypertension; 2021 Jan; 77(1):114-125. PubMed ID: 33249859
[TBL] [Abstract][Full Text] [Related]
30. Adrenalectomy Completely Cured Hypertension in Patients With Familial Hyperaldosteronism Type I Who Had Somatic KCNJ5 Mutation.
Lin YF; Peng KY; Chang CH; Hu YH; Wu VC; Chueh JS; Wu KD
J Clin Endocrinol Metab; 2019 Nov; 104(11):5462-5466. PubMed ID: 31287546
[TBL] [Abstract][Full Text] [Related]
31. Medicine. The genetics of primary aldosteronism.
Funder JW
Science; 2011 Feb; 331(6018):685-6. PubMed ID: 21310991
[No Abstract] [Full Text] [Related]
32. KCNJ5 mutation as a predictor for resolution of hypertension after surgical treatment of aldosterone-producing adenoma.
Kitamoto T; Omura M; Suematsu S; Saito J; Nishikawa T
J Hypertens; 2018 Mar; 36(3):619-627. PubMed ID: 29016532
[TBL] [Abstract][Full Text] [Related]
33. Macrolides Blunt Aldosterone Biosynthesis: A Proof-of-Concept Study in
Caroccia B; Prisco S; Seccia TM; Piazza M; Maiolino G; Rossi GP
Hypertension; 2017 Dec; 70(6):1238-1242. PubMed ID: 28993452
[TBL] [Abstract][Full Text] [Related]
34. Comparative Genomics and Transcriptome Profiling in Primary Aldosteronism.
Aristizabal Prada ET; Castellano I; Sušnik E; Yang Y; Meyer LS; Tetti M; Beuschlein F; Reincke M; Williams TA
Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29642543
[TBL] [Abstract][Full Text] [Related]
35. Primary Aldosteronism: KCNJ5 Mutations and Adrenocortical Cell Growth.
Yang Y; Gomez-Sanchez CE; Jaquin D; Aristizabal Prada ET; Meyer LS; Knösel T; Schneider H; Beuschlein F; Reincke M; Williams TA
Hypertension; 2019 Oct; 74(4):809-816. PubMed ID: 31446799
[TBL] [Abstract][Full Text] [Related]
36. Timeline of Advances in Genetics of Primary Aldosteronism.
Meyer LS; Reincke M; Williams TA
Exp Suppl; 2019; 111():213-243. PubMed ID: 31588534
[TBL] [Abstract][Full Text] [Related]
37. KCNJ5 gene somatic mutations affect cardiac remodelling but do not preclude cure of high blood pressure and regression of left ventricular hypertrophy in primary aldosteronism.
Rossi GP; Cesari M; Letizia C; Seccia TM; Cicala MV; Zinnamosca L; Kuppusamy M; Mareso S; Sciomer S; Iacobone M; Mantero F; Pessina AC
J Hypertens; 2014 Jul; 32(7):1514-21; discussion 1522. PubMed ID: 24759126
[TBL] [Abstract][Full Text] [Related]
38. Characteristics of Japanese aldosterone-producing adenomas with KCNJ5 mutations.
Okamura T; Nakajima Y; Katano-Toki A; Horiguchi K; Matsumoto S; Yoshino S; Yamada E; Tomaru T; Ishii S; Saito T; Ozawa A; Shibusawa N; Satoh T; Okada S; Nagaoka R; Takada D; Horiguchi J; Oyama T; Yamada M
Endocr J; 2017 Jan; 64(1):39-47. PubMed ID: 27681703
[TBL] [Abstract][Full Text] [Related]
39. A Novel Somatic Deletion Mutation of ATP2B3 in Aldosterone-Producing Adenoma.
Murakami M; Yoshimoto T; Minami I; Bouchi R; Tsuchiya K; Hashimoto K; Izumiyama H; Fujii Y; Endo T; Akashi T; Nishimoto K; Mukai K; Kihara K; Ogawa Y
Endocr Pathol; 2015 Dec; 26(4):328-33. PubMed ID: 26481629
[TBL] [Abstract][Full Text] [Related]
40. A novel somatic mutation 145-147delETEinsK in KCNJ5 increases aldosterone production.
Zheng FF; Zhu LM; Zhou WL; Zhang Y; Li MY; Zhu YC; Wang JG; Zhu DL; Gao PJ
J Hum Hypertens; 2017 Nov; 31(11):756-759. PubMed ID: 28974779
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]